End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
876.5 INR | +1.01% | +4.81% | +33.40% |
15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
25/04 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.27B | ||||||
765B | ||||||
354B | - | - | - | - | ||
331B | ||||||
299B | ||||||
248B |